Annual Current Liabilities
$12.68 M
+$1.46 M+13.00%
31 December 2023
Summary:
Leap Therapeutics annual total current liabilities is currently $12.68 million, with the most recent change of +$1.46 million (+13.00%) on 31 December 2023. During the last 3 years, it has risen by +$5.31 million (+72.06%). LPTX annual current liabilities is now -64.92% below its all-time high of $36.16 million, reached on 31 December 2016.LPTX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$16.09 M
+$494.00 K+3.17%
30 September 2024
Summary:
Leap Therapeutics quarterly total current liabilities is currently $16.09 million, with the most recent change of +$494.00 thousand (+3.17%) on 30 September 2024. Over the past year, it has increased by +$5.05 million (+45.80%). LPTX quarterly current liabilities is now -55.49% below its all-time high of $36.16 million, reached on 31 December 2016.LPTX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LPTX Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +13.0% | +45.8% |
| 3 y3 years | +72.1% | +42.9% |
| 5 y5 years | +96.6% | +102.9% |
LPTX Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +72.1% | at high | +119.1% |
| 5 y | 5 years | at high | +96.6% | at high | +139.7% |
| alltime | all time | -64.9% | +746.2% | -55.5% | +2689.1% |
Leap Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $16.09 M(+3.2%) |
| June 2024 | - | $15.60 M(+49.5%) |
| Mar 2024 | - | $10.44 M(-17.7%) |
| Dec 2023 | $12.68 M(+13.0%) | $12.68 M(+14.9%) |
| Sept 2023 | - | $11.04 M(-6.2%) |
| June 2023 | - | $11.76 M(+14.1%) |
| Mar 2023 | - | $10.31 M(-8.1%) |
| Dec 2022 | $11.22 M(+12.4%) | $11.22 M(-4.2%) |
| Sept 2022 | - | $11.72 M(+12.6%) |
| June 2022 | - | $10.41 M(+41.8%) |
| Mar 2022 | - | $7.34 M(-26.5%) |
| Dec 2021 | $9.99 M(+35.5%) | $9.99 M(-11.3%) |
| Sept 2021 | - | $11.26 M(+39.8%) |
| June 2021 | - | $8.06 M(+9.0%) |
| Mar 2021 | - | $7.39 M(+0.3%) |
| Dec 2020 | $7.37 M(-13.1%) | $7.37 M(+9.8%) |
| Sept 2020 | - | $6.71 M(-1.8%) |
| June 2020 | - | $6.84 M(-25.7%) |
| Mar 2020 | - | $9.20 M(+8.4%) |
| Dec 2019 | $8.49 M | $8.49 M(+7.0%) |
| Sept 2019 | - | $7.93 M(-6.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2019 | - | $8.46 M(+3.3%) |
| Mar 2019 | - | $8.19 M(+26.9%) |
| Dec 2018 | $6.45 M(+6.0%) | $6.45 M(+6.7%) |
| Sept 2018 | - | $6.05 M(+0.3%) |
| June 2018 | - | $6.03 M(+3.1%) |
| Mar 2018 | - | $5.84 M(-3.9%) |
| Dec 2017 | $6.08 M(-83.2%) | $6.08 M(+1.5%) |
| Sept 2017 | - | $5.99 M(+37.0%) |
| June 2017 | - | $4.38 M(-5.1%) |
| Mar 2017 | - | $4.61 M(-87.2%) |
| Dec 2016 | $36.16 M(+537.9%) | $36.16 M(+6166.4%) |
| June 2016 | - | $577.00 K(-89.8%) |
| Dec 2015 | $5.67 M(+127.8%) | $5.67 M(+106.9%) |
| Sept 2015 | - | $2.74 M(-2.5%) |
| June 2015 | - | $2.81 M(-0.4%) |
| Mar 2015 | - | $2.82 M(+13.4%) |
| Dec 2014 | $2.49 M(+26.2%) | $2.49 M(+26.2%) |
| Sept 2014 | - | $1.97 M(-38.3%) |
| June 2014 | - | $3.19 M(+16.4%) |
| Mar 2014 | - | $2.75 M(+39.3%) |
| Dec 2013 | $1.97 M(+31.5%) | $1.97 M |
| Dec 2012 | $1.50 M | - |
FAQ
- What is Leap Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Leap Therapeutics?
- What is Leap Therapeutics annual current liabilities year-on-year change?
- What is Leap Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Leap Therapeutics?
- What is Leap Therapeutics quarterly current liabilities year-on-year change?
What is Leap Therapeutics annual total current liabilities?
The current annual current liabilities of LPTX is $12.68 M
What is the all time high annual current liabilities for Leap Therapeutics?
Leap Therapeutics all-time high annual total current liabilities is $36.16 M
What is Leap Therapeutics annual current liabilities year-on-year change?
Over the past year, LPTX annual total current liabilities has changed by +$1.46 M (+13.00%)
What is Leap Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of LPTX is $16.09 M
What is the all time high quarterly current liabilities for Leap Therapeutics?
Leap Therapeutics all-time high quarterly total current liabilities is $36.16 M
What is Leap Therapeutics quarterly current liabilities year-on-year change?
Over the past year, LPTX quarterly total current liabilities has changed by +$5.05 M (+45.80%)